Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: June 3, 2023

Litigation Details for GRUNENTHAL GMBH v. ACTAVIS ELIZABETH LLC (D.N.J. 2013)

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

GRUNENTHAL GMBH v. ACTAVIS ELIZABETH LLC (D.N.J. 2013)

Docket	⤷ Try a Trial	Date Filed	2013-07-25
Court	District Court, D. New Jersey	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Claire Claudia Cecchi
Jury Demand	None	Referred To	Magistrate Judge Mark Falk
Patents	7,994,364; 8,309,060; 8,536,130
Link to Docket	External link to docket

Small Molecule Drugs cited in GRUNENTHAL GMBH v. ACTAVIS ELIZABETH LLC

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Details for GRUNENTHAL GMBH v. ACTAVIS ELIZABETH LLC (D.N.J. 2013)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2018-02-21	618		.2 The patents-in-suit, i.e., U.S. Reissue Patent No. 39,593 (the “RE593 patent”), U.S. Patent No. 7,…7,994,364 (“the ‘364 patent”) and U.S. Patent No. 8,536,130 (“the ‘130 patent”) are directed to compositions…) infringed their patents.3 2 A fourth patent, U.S. Patent No. 8,309,060 (“the…accused of infringing the RE593 and ‘364 patents, but not the ‘130 patent.) While the lead case was filed on…no invalidity of the three patents, or unenforceability of the ‘364 patent. Therefore, pursuant to the	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Moodys

McKinsey

Harvard Business School

Mallinckrodt

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.